These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas]. Zhang X; Wang Y; Gao N; Wang J Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565 [TBL] [Abstract][Full Text] [Related]
8. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218 [TBL] [Abstract][Full Text] [Related]
9. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay. Chang YS; Er TK; Lu HC; Yeh KT; Chang JG Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805 [TBL] [Abstract][Full Text] [Related]
10. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Billah S; Stewart J; Staerkel G; Chen S; Gong Y; Guo M Cancer Cytopathol; 2011 Apr; 119(2):111-7. PubMed ID: 21400670 [TBL] [Abstract][Full Text] [Related]
11. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1). Beau-Faller M; Degeorges A; Rolland E; Mounawar M; Antoine M; Poulot V; Mauguen A; Barbu V; Coulet F; Prétet JL; Bièche I; Blons H; Boyer JC; Buisine MP; de Fraipont F; Lizard S; Olschwang S; Saulnier P; Prunier-Mirebeau D; Richard N; Danel C; Brambilla E; Chouaid C; Zalcman G; Hainaut P; Michiels S; Cadranel J J Thorac Oncol; 2011 Jun; 6(6):1006-15. PubMed ID: 21532509 [TBL] [Abstract][Full Text] [Related]
12. Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection. Davidson CJ; Zeringer E; Champion KJ; Gauthier MP; Wang F; Boonyaratanakornkit J; Jones JR; Schreiber E Biotechniques; 2012 Sep; 53(3):182-8. PubMed ID: 22963480 [TBL] [Abstract][Full Text] [Related]
13. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer. Netzel BC; Grebe SK Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066 [TBL] [Abstract][Full Text] [Related]
14. Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues. Guo W; Zhang C; Wu J; Song B; Wang B; Zhou Y; Zhou J; Shen M; Zhang C; Zhang X; Guan M; Pan B Clin Chem Lab Med; 2012 Jan; 50(6):1035-40. PubMed ID: 22706243 [TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations. Chevrier S; Arnould L; Ghiringhelli F; Coudert B; Fumoleau P; Boidot R Int J Oncol; 2014 Sep; 45(3):1167-74. PubMed ID: 24990411 [TBL] [Abstract][Full Text] [Related]
16. KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer. Malapelle U; Sgariglia R; De Stefano A; Bellevicine C; Vigliar E; de Biase D; Sepe R; Pallante P; Carlomagno C; Tallini G; Troncone G J Clin Pathol; 2015 Apr; 68(4):265-9. PubMed ID: 25609577 [TBL] [Abstract][Full Text] [Related]
17. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens. Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527 [TBL] [Abstract][Full Text] [Related]
18. Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers. Dudley J; Tseng LH; Rooper L; Harris M; Haley L; Chen G; Gocke CD; Eshleman JR; Lin MT Arch Pathol Lab Med; 2015 Feb; 139(2):211-8. PubMed ID: 25611103 [TBL] [Abstract][Full Text] [Related]
19. KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics. Rechsteiner M; von Teichman A; Rüschoff JH; Fankhauser N; Pestalozzi B; Schraml P; Weber A; Wild P; Zimmermann D; Moch H J Mol Diagn; 2013 May; 15(3):299-311. PubMed ID: 23531339 [TBL] [Abstract][Full Text] [Related]